Anika Therapeutics, Inc.
ANIK
$9.05
$0.688.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.97M | -4.87M | -- | -29.92M | -88.00K |
| Total Depreciation and Amortization | 1.42M | 1.59M | -- | 2.19M | 2.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.20M | 3.42M | -- | 31.25M | 5.00M |
| Change in Net Operating Assets | -3.83M | -269.00K | -- | 1.49M | -8.04M |
| Cash from Operations | -189.00K | -130.00K | -- | 5.02M | -1.07M |
| Capital Expenditure | -1.47M | -2.82M | -- | -1.22M | -3.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 4.50M | -- | -- | -- | -- |
| Other Investing Activities | -3.57M | 4.50M | -- | -600.00K | -- |
| Cash from Investing | -539.00K | 1.67M | -- | -1.82M | -3.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 261.00K | -- | -- | 0.00 | 464.00K |
| Repurchase of Common Stock | -82.00K | -5.44M | -- | -3.99M | -1.58M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 179.00K | -5.44M | -- | -3.99M | -1.11M |
| Foreign Exchange rate Adjustments | 345.00K | 108.00K | -- | 337.00K | -224.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.00K | -3.79M | -- | -454.00K | -5.81M |